Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2026 · 10-Q
Revenue$41.93M$41.93M+6.1% vs Q2 2025 Net Income-$3.59M-$3.59MN/M vs Q2 2025 EPS Diluted-$0.01-$0.01— vs Q2 2025 Gross Profit$16,225,000+1.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,219,000+647.1% Free Cash Flowderived$1,921,000N/M Margins · derivedGross margin38.7%−1.6 pt vs Q2 2025
Operating margin1.0%−1.6 pt vs Q2 2025
Net margin-8.6%−5.0 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d after period end